Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
about
CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genesChromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasRole of CHD5 in human cancers: 10 years laterCHD5 is required for spermiogenesis and chromatin condensationChd5 requires PHD-mediated histone 3 binding for tumor suppressionDifferential expression and sex chromosome association of CHD3/4 and CHD5 during spermatogenesisThe tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.Multivalent recognition of histone tails by the PHD fingers of CHD5Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromesA three-gene expression signature model for risk stratification of patients with neuroblastomaTherapeutic targets for neuroblastomas.The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1.The tumour suppressor CHD5 forms a NuRD-type chromatin remodelling complex.Mechanisms of CHD5 Inactivation in neuroblastomas.The chromatin remodeler chd5 is necessary for proper head development during embryogenesis of Danio rerio.Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas.Silencing of CHD5 gene by promoter methylation in leukemia.Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.Apoptotic cell death in neuroblastoma.The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Chromatin regulators with tumor suppressor properties and their alterations in human cancers.Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.Decreased expression of chromodomain helicase DNA-binding protein 5 is an unfavorable prognostic marker in patients with primary gallbladder carcinoma.Locoregional MYCN-amplified neuroblastoma
P2860
Q24338318-E8B49F30-882A-46AD-88BB-C6075B9FEA78Q26751724-57703179-3419-4752-B747-AF16861B7A40Q27006929-3367F0D7-E153-4296-AA62-712BD60FF723Q28510857-C91FCAF3-F1E9-4077-8382-AFB15BA8FB76Q28593132-58299C7C-F3E9-475B-BDBC-DDA1A681B00CQ33646049-119A3919-EA13-4C8B-8A03-4810A5C8F59AQ33947091-DAB8D418-BE9E-4A10-BC82-34D0B8F68943Q34352597-A28E4B78-7F28-4C49-9D1A-F9D9C7BA1342Q34520690-54158712-9824-40DA-9088-1E0004BFCFECQ34559142-68D85022-8327-4018-9CF1-38A9DFB27AE3Q34560877-CA71F74B-B1E4-4CF8-9830-6F0F387EE0DBQ35270535-012E7C02-2BE7-4ACF-B12D-42FBD0AE0349Q35806478-F6905F72-9941-4EDD-AA0E-8C3FFE7EB59AQ35836491-C0FE635F-4BFB-40D2-8E98-9FF3181BA3BBQ35982052-9E8C40B8-5498-4206-A8B4-6510488C1608Q37085930-582FCC8F-3E32-4DCD-9273-10AB199F9B01Q37472949-51BE0A84-94E4-4C32-97FC-8506B20291C7Q37626242-438C8CB9-98B5-442B-A76C-A78A1D758DAAQ37679253-21AD6979-C717-4157-9154-96D58902A6DAQ37735355-6D14F927-5020-4037-AF17-D21C6F775476Q38014527-19241CDD-2A5E-48DE-A5A7-D6A2268095F3Q38058125-357F5862-0A93-4231-8000-1A6E12105834Q40310537-232F4D45-B83A-413A-904B-1B6C09CEB976Q41786481-ABD133B1-6C81-4F08-8535-E23B35E238EEQ43989091-22B97C5F-7180-42B7-9600-BAEDB28B7EC4Q45921428-51056E17-14CE-4965-9DB3-1630BF9FC8DEQ57734210-34E4082A-0BF4-4162-8CC6-F32DB299268A
P2860
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@en
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@nl
type
label
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@en
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@nl
prefLabel
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@en
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Expression of the neuron-speci ...... r of outcome in neuroblastoma.
@en
P2093
Antonio R Perez-Atayde
Carla Casala
Carmen de Torres
Cinzia Lavarino
Eva Rodríguez
Gemma Mayol
Idoia Garcia
Jaume Mora
Mariona Suñol
P2860
P2888
P356
10.1186/1476-4598-9-277
P577
2010-10-15T00:00:00Z
P5875
P6179
1049150866